All In Biotech

Drug Trial Radar · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab in Adult Participants With COPD With Type 2 Inflammation

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 961 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

961

Planned (sponsor's estimate)

Start

Jun 23, 2025

Primary completion

Dec 13, 2028

Study completion Feb 14, 2029

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
May 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab compared as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • DepemokimabBiological

    Depemokimab as a sterile liquid formulation will be administered.

  • PlaceboDrug

    Placebo as a sterile 0.9 percent (%) sodium chloride solution will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized Rate of Moderate/Severe ExacerbationsTime frame: From Baseline up to Week 104

Locations

193 sites in 16 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Sheffield, Alabama · Recruiting

  • GSK Investigational Site

    Aurora, Colorado · Recruiting

  • GSK Investigational Site

    Brooksville, Florida · Recruiting

  • GSK Investigational Site

    Doral, Florida · Recruiting

  • GSK Investigational Site

    Fort Lauderdale, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Naples, Florida · Recruiting

  • GSK Investigational Site

    New Port Richey, Florida · Recruiting

  • GSK Investigational Site

    Ocala, Florida · Recruiting

  • GSK Investigational Site

    Orlando, Florida · Recruiting

  • GSK Investigational Site

    Ormond Beach, Florida · Recruiting

  • GSK Investigational Site

    Palmetto Bay, Florida · Recruiting

  • GSK Investigational Site

    Pembroke Pines, Florida · Recruiting

  • GSK Investigational Site

    St. Petersburg, Florida · Recruiting

  • GSK Investigational Site

    Adairsville, Georgia · Recruiting

  • GSK Investigational Site

    Atlanta, Georgia · Recruiting

  • GSK Investigational Site

    Cordele, Georgia · Recruiting

  • GSK Investigational Site

    Morrow, Georgia · Recruiting

  • GSK Investigational Site

    Boise, Idaho · Recruiting

  • GSK Investigational Site

    Chicago, Illinois · Recruiting

  • GSK Investigational Site

    Baton Rouge, Louisiana · Recruiting

  • GSK Investigational Site

    Lafayette, Louisiana · Recruiting

  • GSK Investigational Site

    Shreveport, Louisiana · Recruiting

  • GSK Investigational Site

    Bangor, Maine · Recruiting

  • GSK Investigational Site

    Rockville, Maryland · Recruiting

  • GSK Investigational Site

    Fall River, Massachusetts · Recruiting

  • GSK Investigational Site

    Allen Park, Michigan · Recruiting

  • GSK Investigational Site

    Detroit, Michigan · Recruiting

  • GSK Investigational Site

    Garden City, Michigan · Recruiting

  • GSK Investigational Site

    Troy, Michigan · Recruiting

  • GSK Investigational Site

    Las Vegas, Nevada · Recruiting

  • GSK Investigational Site

    Moorestown, New Jersey · Recruiting

  • GSK Investigational Site

    Sewell, New Jersey · Recruiting

Showing 40 of 193 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.